[ Price : $8.95]
FDA clears a Canon Medical Systems 510(k) for its new premium MRI system, Vantage Orian 1.5T.[ Price : $8.95]
FDA accepts for priority review a Genentech supplemental BLA for Tecentriq (atezolizumab) plus chemotherapy for first-line treatme...[ Price : $8.95]
FDA approves a PolyPid Ltd. IND for it to proceed with a Phase 3 clinical trial involving lead candidate D-Plex[100] for preventin...[ Price : $8.95]
Federal Register notice: FDA seeks comments on an information collection extension on a guidance for Medical Device User Fee Small...[ Price : $8.95]
A Tufts Center for the Study of Drug Development analysis says the global biotech product development surge that started in the 19...[ Price : $8.95]
FDA issues a draft guidance on considerations for using a metastasis-free survival endpoint in some prostate cancer drug trials.[ Price : $8.95]
FDA releases its latest batch of Warning Letters that include StemGenex Biologic Laboratories and U.S. Vascular.[ Price : $8.95]
FDA accepts for review a Shire supplemental NDA to expand the indication of Gattex (teduglutide [rDNA origin]) for injection to pe...